Navigation Links
Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
Date:6/18/2008

ny advancing individualized medicine by discovering, developing and marketing innovative products to guide and improve treatment of serious infectious diseases and cancer. The Company's products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. The Company's technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines as well as targeted cancer therapeutics. More information about the Company and its technology can be found on its web site at http://www.monogrambio.com.

About Monogram's Assays

As recommended by the U.S. FDA Antiviral Drugs Advisory Committee, biopharmaceutical companies use HIV resistance testing technology to support and enhance next-generation HIV drug development. Monogram's proprietary technology is being applied to new HIV drug targets for screening and in subsequent clinical development programs for optimization of background therapy, patient monitoring and, in the case of CCR5 antagonists, for patient selection. Monogram is a leader in providing drug susceptibility and tropism assays for pharmaceutical development. PhenoSense GT(TM) is the only assay combining actual phenotype and genotype drug results in a single report. PhenoSense GT also includes a measure of replication capacity (RC), sometimes called viral fitness, and HIV-1 subtype. PhenoSense Entry(TM) is the only commercially available phenotypic test for measuring susceptibility to entry inhibitors. Similarly, PhenoSense Integrase(TM), which is a phenotypic test for measuring susceptibility to integrase inhibitors, is expected to be introduced commercially soon. Trofile(TM) is a patient selection co-receptor tropism assay that determines whether a patient is infected with a strain of HIV that uses the CCR5 co-receptor, the CXCR4 co-receptor, or a combination of CCR5 and C
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Monogram Announces First Medicare Payment for Trofile(TM)
2. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
3. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
4. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
5. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
6. Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th
7. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
8. Pressure BioSciences, Inc. to Discuss Third Quarter Financial Results and Provide Business Update
9. Anaptys Biosciences Raises Over $33 Million in Series B Financing
10. YM BIOSCIENCES REPORTS FIRST QUARTER 2008 OPERATIONAL AND FINANCIAL RESULTS
11. Pressure BioSciences, Inc. Reports Third Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 22, 2013 Swimsuit season is almost here. ... ® products has begun with a 35% discount. , Cellulite ... Many women get the dreaded cellulite even if they are ... skin where they have been stored as toxic lymph and ... easy fixes, a specific program that works to dissolve the ...
(Date:5/21/2013)... WASHINGTON (May 22, 2013)Today the George Washington ... Health Services (SPHHS) announced the launch of ... Immigrant/Refugee Health, a collaboration between SPHHS, the ... and other community partners. This university-community partnership ... disproportionately affect Latino communities through research, mutual ...
(Date:5/21/2013)... 21, 2013 DISCcert has served the ... to use 17 DISC applications at the July 25 ... progression. , The July 25 & 26th DISC certification ... ways of applying DISC. The time-tested, proven support materials ... user-friendly DISC training materials ; worksheets, handouts, ...
(Date:5/21/2013)... 21, 2013 ContinuCare Home Health, Inc. ... of Aging and Disability Services. After completing a four-day ... ContinuCare Home Health was found to have no ... part of the Department of Aging and Disability Services’ ... disability services, supports and opportunities that are easily ...
(Date:5/21/2013)... 21, 2013 Artisan Business Group ... Summit: Dealmakers Conference in Long Beach, California on ... on exploring alternative finance through EB-5 immigrant investors ... legal and economic information, and updates to project ... within the EB-5 industry. , "Our goal ...
Breaking Medicine News(10 mins):Health News:Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale" 2Health News:GW launches center to address health disparities in the Latino immigrant community 2Health News:GW launches center to address health disparities in the Latino immigrant community 3Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2
... regional pain syndrome is a neurological disorder caused by continuous ... sense pain. // ,This syndrome includes all the post-traumatic ... injury has healed. But the causes of the symptoms of ... the fact that there are very few objective findings, diagnosis ...
... British Prime Minister Tony Blair today formally inducted 11 private ... further step towards increasing competition in the health sector. //Mr ... members at a summit held at Downing Street to mark ... signed a document pledging to work as partners towards 'future ...
... is the key to weight loss a new study says ... //, ,This study comes from the Canadian Institute for ... work can help make or break our battle against the ... CIHI's Canadian Population Health Initiative, "We see that the majority ...
... pollution in the air now that if it weren't for ... -Robert Orben // ,The order of the ... Clemenceau to be sent back to France, represents the overall ... The order has been issued following dismissal of the proposed ...
... profound impact on either couple, men seem to be more ... Christakis and his research team from Harvard Medical School. ... spouse on the risk of illness in the other partner ... elderly couples. ,They found that when a spouse ...
... at the Washington Hospital Center studied the use of ... blocked arteries. // ,These blocked arteries are ... as it leads to devastating complications such as amputation. ... high blood pressure are at high risk for losing ...
Cached Medicine News:Health News:Location largely affects weight 2Health News:The Return Of The Clemenceau: Happy India 2Health News:Laser Used To Clear Blocked Arteries Preventing Amputation, 2
(Date:5/21/2013)... , May 21, 2013 U.S. spending on ... complex diseases such as cancer, multiple sclerosis and rheumatoid ... the end of 2015, according to a forecast released ... (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO ) "As we ... and health plans to act so they can continue ...
(Date:5/21/2013)... , May 21, 2013 Reportlinker.com ... is available in its catalogue: ... Reimbursement Scenario for Medical Devices in the ...   Changing Regulatory and ... US Market   ...
(Date:5/21/2013)... 21, 2013  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... company focused on the development and commercialization ... acute and breakthrough pain, today announced top-line ... 3 study of its investigational sublingual Sufentanil ... the primary efficacy endpoint was achieved.  The ...
Breaking Medicine Technology:U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 2U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 3U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 4U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 5Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10
For radial/ulnar translation, angulation, dorsal/volar translation, and incremental longitudinal distraction, this advanced system is appropriate when incremental adjustment provides an adjunctive me...
Provides basic reduction capabilities for angulation, rotation and length. Ball joint design offers fracture reduction in all planes....
... The Holding Clamps have a slender design ... sequential tensioning of Kirschner wires. The Connecting ... Fiber Rods and/or Connecting Bar. Uses 3.0 ... tip Kirschner wires eliminate need to predrill ...
The Elbow Fixator has ontrolled movement about the axis of rotation of the elbow joint. It is minimally invasive and rapidly applied....
Medicine Products: